News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trevena, Inc. (TRVN) CEO To Present At The Jefferies and Co. 2014 Global Healthcare Conference



5/27/2014 6:47:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 11:00 a.m. EDT in New York City.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES